Beyond Glycemia in T1D
Endocrinology and Metabolism Clinics of North America · 2026-09 · 55 (3) · 395-405
DOI: 10.1016/j.ecl.2026.04.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism Clinics of North America, 2026-09. Verfasst von Jairo A Pinzon Cortes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology Metabolism and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA; Diabetes D…. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 1, Cardiovascular Diseases, Diabetic Nephropathies. Die Arbeit nennt 48 Literaturangaben. Gefördert von: NIDDK NIH HHS, American Heart Association Inc, NIH.
Abstract (Originalsprache)
Insulin resistance (IR) is an underrecognized feature of type 1 diabetes (T1D), present even in lean individuals. Rising obesity rates have further amplified this burden, creating a mixed metabolic phenotype that accelerates cardiorenal disease. Paradoxically, despite fewer traditional cardiovascular risk factors, individuals with T1D experience higher rates of cardiorenal complications than those with type 2 diabetes, a gap not fully explained by glycemic control. This article examines the epidemiologic, pathophysiologic, and mechanistic underpinnings of this hidden cardiorenal risk, including key drivers of end-organ damage. Broader therapeutic interventions targeting IR in T1D are essential to prevent future cardiorenal disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology Metabolism and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA; Diabetes Department, School of Translational Medicine, Monash University, Melbou…
- Division of Endocrinology Metabolism and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Ch…
- Department of Internal and Vascular Medicine, Amsterdam University Medical Center location AMC, Amsterdam, Netherlands.
- School of Medicine, Universidad Cientifica del Sur, Lima, Peru; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
- Division of Endocrinology Metabolism and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA; University of Washington Medicine Diabetes Institute; Enrichment Program, Univer…
- Section of Pediatric Endocrinology, Clinical and Translational Research, School of Medicine, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, CO, USA.
Förderung
- NIDDK NIH HHS
- American Heart Association Inc
- NIH
- Breakthrough T1D
- American Diabetes Association
Zitieren
APA
Pinzon Cortes, J. A., Narongkiatikhun, P., Fuhri Snethlage, C. M., Del Castillo, D., Tommerdahl, K. L., Nadeau, K. J., & Bjornstad, P. (2026). Beyond Glycemia in T1D. Endocrinology and Metabolism Clinics of North America, 55(3), 395-405. https://doi.org/10.1016/j.ecl.2026.04.008
Vancouver
Pinzon Cortes JA, Narongkiatikhun P, Fuhri Snethlage CM, Del Castillo D, Tommerdahl KL, Nadeau KJ, et al. Beyond Glycemia in T1D. Endocrinology and Metabolism Clinics of North America. 2026;55(3):395-405. doi:10.1016/j.ecl.2026.04.008
BibTeX
@article{PinzonCortes2026,
author = {Pinzon Cortes, Jairo A and Narongkiatikhun, Phoom and Fuhri Snethlage, Coco M and Del Castillo, Darwin and Tommerdahl, Kalie L and Nadeau, Kristen J and Bjornstad, Petter},
title = {Beyond Glycemia in T1D},
journal = {Endocrinology and Metabolism Clinics of North America},
year = {2026},
volume = {55},
number = {3},
pages = {395--405},
doi = {10.1016/j.ecl.2026.04.008}
}
EUVIMED